In this blog, members from our research team in Canada share a little bit of insight into Health Canada's newest call for participation in the development of a national strategy for high-cost drugs.
To read more: https://www.socialpharmaceuticalinnovation.org/post/national-strategy-on-high-cost-drug-discussion-paper
Share your thoughts on this with us below: